A detailed history of Intech Investment Management LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Intech Investment Management LLC holds 38,709 shares of RLAY stock, worth $256,253. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,709
Previous 54,243 28.64%
Holding current value
$256,253
Previous $187,000 8.02%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

SELL
$3.22 - $5.22 $50,019 - $81,087
-15,534 Reduced 28.64%
38,709 $202,000
Q2 2025

Aug 08, 2025

SELL
$2.0 - $3.49 $54,370 - $94,875
-27,185 Reduced 33.39%
54,243 $187,000
Q1 2025

May 20, 2025

BUY
$2.62 - $4.92 $88,511 - $166,212
33,783 Added 70.91%
81,428 $213,000
Q4 2024

Feb 10, 2025

BUY
$4.12 - $6.8 $47,252 - $77,989
11,469 Added 31.7%
47,645 $196,000
Q3 2024

Nov 08, 2024

BUY
$6.23 - $9.51 $225,376 - $344,033
36,176 New
36,176 $256,000

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $796M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.